NFE2L2 and neoplasm: Importantly, NRF2 has previously been shown to inhibit the immunosuppressive actions of MDSCs in mouse models by eliminating ROS and allowing for tumor immunity by protecting regulatory T-cells, which are vulnerable to oxidative stress [27,28].